The University of Chicago Header Logo

Peter Hulick

Concepts (314)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
BRCA1 Protein
20
2023
222
1.830
Why?
Genetic Predisposition to Disease
39
2026
2588
1.790
Why?
BRCA2 Protein
17
2025
178
1.770
Why?
Precision Medicine
10
2026
512
1.400
Why?
Breast Neoplasms
26
2023
3303
1.350
Why?
Ovarian Neoplasms
15
2023
829
1.320
Why?
Genetic Testing
11
2026
610
1.290
Why?
Pharmacogenetics
7
2024
474
1.220
Why?
Mutation
24
2023
4443
0.910
Why?
Genes, BRCA2
7
2019
162
0.890
Why?
Genes, BRCA1
7
2019
191
0.890
Why?
Heterozygote
17
2025
393
0.770
Why?
Germ-Line Mutation
9
2025
404
0.730
Why?
Primary Health Care
3
2021
408
0.730
Why?
Genetics, Population
2
2021
451
0.640
Why?
Delivery of Health Care, Integrated
1
2021
72
0.630
Why?
Polymorphism, Single Nucleotide
17
2022
2577
0.630
Why?
Patients
1
2021
105
0.610
Why?
Genome-Wide Association Study
12
2021
1863
0.610
Why?
Prostatic Neoplasms
9
2022
1846
0.590
Why?
Health Literacy
1
2021
92
0.580
Why?
Patient Acceptance of Health Care
2
2026
315
0.520
Why?
Drug-Related Side Effects and Adverse Reactions
2
2019
220
0.520
Why?
Genomics
7
2026
914
0.490
Why?
Multifactorial Inheritance
4
2026
236
0.460
Why?
Humans
77
2026
98799
0.460
Why?
Risk Factors
23
2026
6295
0.430
Why?
Chromosomes, Human, Pair 9
2
2016
81
0.420
Why?
Female
54
2026
51997
0.420
Why?
Neoplasms
7
2026
3382
0.410
Why?
High-Throughput Nucleotide Sequencing
5
2026
588
0.400
Why?
Adult
34
2026
29698
0.380
Why?
Risk Assessment
11
2026
2604
0.380
Why?
Middle Aged
31
2026
29642
0.370
Why?
Delivery of Health Care
2
2018
483
0.360
Why?
Early Detection of Cancer
2
2014
563
0.360
Why?
Pharmacogenomic Testing
3
2018
119
0.350
Why?
Biological Specimen Banks
4
2026
83
0.330
Why?
Physicians
2
2021
687
0.330
Why?
Pedigree
8
2025
988
0.310
Why?
Biomarkers, Tumor
4
2026
1786
0.310
Why?
Comparative Genomic Hybridization
1
2010
41
0.310
Why?
Cytogenetic Analysis
1
2010
70
0.300
Why?
Alleles
6
2021
1163
0.300
Why?
Mendelian Randomization Analysis
2
2019
54
0.280
Why?
Male
31
2026
47475
0.280
Why?
Aged
22
2026
21986
0.280
Why?
Body Height
2
2019
111
0.280
Why?
Mastectomy
3
2016
277
0.280
Why?
Chromosome Aberrations
1
2010
353
0.270
Why?
Abnormalities, Multiple
1
2010
236
0.270
Why?
Diabetes Mellitus, Type 1
2
2024
687
0.260
Why?
Chromosome Mapping
3
2020
1064
0.240
Why?
Quantitative Trait Loci
6
2021
665
0.240
Why?
Hypertrichosis
1
2025
5
0.230
Why?
Hand Deformities, Congenital
1
2025
16
0.230
Why?
Cryptorchidism
1
2025
12
0.230
Why?
Smad4 Protein
1
2025
27
0.230
Why?
Patient Reported Outcome Measures
2
2021
337
0.230
Why?
Genetic Diseases, Inborn
1
2026
105
0.230
Why?
Hereditary Breast and Ovarian Cancer Syndrome
1
2025
12
0.220
Why?
Diabetes Mellitus, Type 2
2
2024
1293
0.220
Why?
Penetrance
1
2025
51
0.220
Why?
Genetic Counseling
1
2025
111
0.220
Why?
Body Mass Index
2
2019
869
0.220
Why?
Colorectal Neoplasms
3
2025
1120
0.220
Why?
Phenotype
8
2025
2673
0.220
Why?
Receptors, Estrogen
3
2020
431
0.220
Why?
Prostate
2
2022
434
0.210
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2025
54
0.210
Why?
Intellectual Disability
1
2025
216
0.210
Why?
Aged, 80 and over
8
2026
7461
0.200
Why?
Patient Transfer
1
2014
116
0.190
Why?
Community Health Planning
3
2018
23
0.190
Why?
United Kingdom
4
2026
217
0.190
Why?
Software
2
2020
698
0.180
Why?
DNA Copy Number Variations
3
2022
207
0.180
Why?
Case-Control Studies
7
2020
2017
0.180
Why?
Prospective Studies
8
2026
4837
0.180
Why?
Exome
3
2021
150
0.180
Why?
Genes, Dominant
2
2025
112
0.170
Why?
Medical History Taking
2
2025
81
0.170
Why?
Genotype
7
2021
1895
0.170
Why?
Coronary Artery Disease
1
2026
391
0.170
Why?
Genetic Variation
3
2019
1460
0.160
Why?
Inpatients
1
2014
371
0.160
Why?
Heart Arrest
1
2014
315
0.160
Why?
Mutation, Missense
2
2020
312
0.160
Why?
Venous Thromboembolism
1
2023
178
0.160
Why?
Health Personnel
2
2021
259
0.160
Why?
Urogenital Abnormalities
1
2020
19
0.160
Why?
Intensive Care Units
1
2014
476
0.160
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2020
69
0.160
Why?
Young Adult
7
2021
7598
0.160
Why?
Patient Readmission
1
2024
441
0.160
Why?
Thrombosis
1
2023
319
0.160
Why?
Urinary Tract
1
2020
34
0.160
Why?
Electronic Health Records
1
2014
456
0.150
Why?
Lung Neoplasms
3
2023
2474
0.150
Why?
Cystic Fibrosis
1
2020
124
0.150
Why?
Hereditary Sensory and Motor Neuropathy
1
2019
1
0.150
Why?
Forkhead Transcription Factors
1
2020
185
0.150
Why?
Hexokinase
1
2019
23
0.140
Why?
Illinois
1
2021
531
0.140
Why?
Nipples
2
2016
40
0.140
Why?
Cohort Studies
5
2024
3242
0.140
Why?
Inheritance Patterns
1
2019
55
0.140
Why?
Databases, Genetic
3
2018
290
0.140
Why?
Epigenesis, Genetic
2
2020
595
0.130
Why?
Erythrocytes
1
2019
242
0.130
Why?
Internationality
1
2018
80
0.130
Why?
Exons
2
2016
458
0.130
Why?
Prognosis
6
2019
4139
0.130
Why?
Genetic Association Studies
4
2020
317
0.130
Why?
Genes, Modifier
1
2017
5
0.130
Why?
Alzheimer Disease
1
2023
649
0.130
Why?
Repressor Proteins
1
2020
450
0.130
Why?
Surveys and Questionnaires
3
2021
3058
0.130
Why?
DNA-Binding Proteins
2
2020
1275
0.120
Why?
Community Pharmacy Services
1
2016
6
0.120
Why?
Tumor Suppressor Proteins
2
2016
318
0.120
Why?
Homeodomain Proteins
1
2020
568
0.120
Why?
Point Mutation
2
2016
236
0.120
Why?
Professional Role
1
2016
40
0.120
Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
65
0.120
Why?
Chromosomes, Human, Pair 19
1
2016
61
0.120
Why?
Genetic Carrier Screening
1
2016
58
0.120
Why?
Chromosomes, Human, Pair 12
1
2016
64
0.120
Why?
Adenomatous Polyps
1
2016
15
0.120
Why?
Retrospective Studies
9
2024
11104
0.120
Why?
Neoplasms, Glandular and Epithelial
1
2017
81
0.120
Why?
Adolescent
7
2026
10168
0.120
Why?
Adenomatous Polyposis Coli Protein
1
2016
42
0.120
Why?
Codon, Terminator
1
2015
20
0.120
Why?
Breast Neoplasms, Male
1
2016
34
0.120
Why?
Adenomatous Polyposis Coli
1
2016
44
0.120
Why?
Health Knowledge, Attitudes, Practice
1
2021
608
0.110
Why?
Transcriptome
2
2020
828
0.110
Why?
Genetic Loci
1
2017
263
0.110
Why?
Chromosomes, Human, Pair 6
1
2016
127
0.110
Why?
Proportional Hazards Models
3
2019
925
0.110
Why?
Cross-Sectional Studies
1
2021
2077
0.110
Why?
Connective Tissue Diseases
1
2015
76
0.110
Why?
Estrogen Receptor alpha
1
2016
159
0.110
Why?
Linkage Disequilibrium
3
2021
484
0.110
Why?
Ovariectomy
1
2014
98
0.100
Why?
Risk Reduction Behavior
1
2014
102
0.100
Why?
Mucin-1
1
2014
46
0.100
Why?
Patient Care Team
1
2016
318
0.100
Why?
Estrone
1
2013
10
0.100
Why?
G2 Phase
1
2013
32
0.100
Why?
Membrane Glycoproteins
1
2015
446
0.100
Why?
Cell Cycle Proteins
1
2016
420
0.100
Why?
Survival Analysis
3
2019
1530
0.090
Why?
Stomach Neoplasms
1
2016
321
0.090
Why?
Infant
3
2020
3368
0.090
Why?
Carrier Proteins
1
2016
670
0.090
Why?
Patient Satisfaction
1
2016
519
0.090
Why?
Transcription Factors
1
2020
1724
0.090
Why?
Polycystic Kidney, Autosomal Dominant
1
2014
150
0.090
Why?
Cell Division
1
2013
690
0.090
Why?
Head and Neck Neoplasms
1
2019
1091
0.090
Why?
Prostate-Specific Antigen
1
2014
356
0.090
Why?
DNA Mutational Analysis
4
2016
554
0.080
Why?
Micrognathism
1
2010
11
0.080
Why?
Eye Abnormalities
1
2010
42
0.080
Why?
Karyotyping
1
2010
220
0.080
Why?
Chromosome Deletion
1
2010
219
0.070
Why?
Gene Duplication
1
2010
130
0.070
Why?
Bayes Theorem
2
2022
423
0.070
Why?
In Situ Hybridization, Fluorescence
1
2010
369
0.070
Why?
Adenocarcinoma
1
2016
1215
0.070
Why?
Chicago
1
2013
1520
0.070
Why?
Developmental Disabilities
1
2010
217
0.070
Why?
Gene Expression
3
2016
1322
0.070
Why?
Family
2
2020
330
0.060
Why?
Genome, Human
1
2012
834
0.060
Why?
Peer Review
1
2006
20
0.060
Why?
Population Surveillance
2
2019
218
0.060
Why?
Lipoprotein(a)
1
2026
33
0.060
Why?
Accreditation
1
2006
80
0.060
Why?
Facies
1
2025
34
0.060
Why?
Child, Preschool
2
2025
4053
0.060
Why?
Growth Disorders
1
2025
65
0.060
Why?
Documentation
1
2006
114
0.060
Why?
Homozygote
2
2023
213
0.060
Why?
Quality Assurance, Health Care
1
2006
229
0.050
Why?
Risk
2
2016
662
0.050
Why?
Dimensional Measurement Accuracy
1
2014
4
0.050
Why?
Radiation Oncology
1
2006
130
0.050
Why?
Guideline Adherence
1
2006
251
0.050
Why?
Protein Binding
2
2020
1564
0.050
Why?
Hospital Rapid Response Team
1
2014
29
0.050
Why?
Drug Interactions
1
2024
240
0.050
Why?
Odds Ratio
2
2016
728
0.050
Why?
Molecular Targeted Therapy
1
2026
331
0.050
Why?
Health Care Costs
1
2026
269
0.050
Why?
Early Diagnosis
1
2014
141
0.050
Why?
United States
4
2024
8387
0.050
Why?
Academic Medical Centers
1
2026
416
0.050
Why?
Factor V
1
2023
10
0.050
Why?
Prothrombin
1
2023
19
0.050
Why?
RNA, Messenger
2
2022
2076
0.050
Why?
Apolipoprotein E4
1
2023
34
0.050
Why?
Promoter Regions, Genetic
2
2016
979
0.050
Why?
Gene Expression Profiling
2
2019
1572
0.050
Why?
Social Determinants of Health
1
2024
149
0.050
Why?
Virulence
1
2023
280
0.040
Why?
Apolipoproteins E
1
2023
139
0.040
Why?
Computational Biology
2
2016
620
0.040
Why?
Multicenter Studies as Topic
1
2022
195
0.040
Why?
Image-Guided Biopsy
1
2022
81
0.040
Why?
Sequence Analysis, DNA
2
2016
920
0.040
Why?
Bernard-Soulier Syndrome
1
2000
1
0.040
Why?
Gallbladder Neoplasms
1
2020
24
0.040
Why?
Biopsy
2
2015
1226
0.040
Why?
Amphibian Proteins
1
2020
4
0.040
Why?
Calibration
1
2020
109
0.040
Why?
Morpholinos
1
2020
13
0.040
Why?
Models, Statistical
1
2014
602
0.040
Why?
Age Factors
2
2016
1976
0.040
Why?
Xenopus
1
2020
120
0.040
Why?
Gene Expression Regulation, Neoplastic
2
2016
1400
0.040
Why?
Diagnosis, Differential
1
2024
1571
0.040
Why?
Glycine
1
2020
97
0.040
Why?
Sequence Deletion
1
2020
208
0.040
Why?
Glutamic Acid
1
2020
136
0.040
Why?
Larva
1
2020
139
0.040
Why?
Vesicular Transport Proteins
1
2020
71
0.040
Why?
Neoplasm Staging
2
2016
2087
0.040
Why?
Cell Line
2
2015
2484
0.040
Why?
Bronchi
1
2020
229
0.040
Why?
Amino Acid Substitution
1
2020
336
0.040
Why?
Estrogens
1
2020
202
0.040
Why?
Retinitis Pigmentosa
1
2019
37
0.040
Why?
Haploinsufficiency
1
2019
79
0.040
Why?
Regulatory Sequences, Nucleic Acid
1
2020
172
0.040
Why?
Menopause
1
2019
95
0.030
Why?
Lymphoma, Non-Hodgkin
1
2020
262
0.030
Why?
Gene Frequency
1
2020
716
0.030
Why?
Mice
3
2020
12762
0.030
Why?
Child
2
2020
7771
0.030
Why?
Telomere-Binding Proteins
1
2017
14
0.030
Why?
Disclosure
1
2018
98
0.030
Why?
Pregnancy-Specific beta 1-Glycoproteins
1
2017
1
0.030
Why?
Transcription Factors, TFII
1
2017
2
0.030
Why?
Cytochrome P450 Family 2
1
2017
4
0.030
Why?
Glutamate Carboxypeptidase II
1
2017
7
0.030
Why?
Geography
1
2018
250
0.030
Why?
Magnetic Resonance Imaging
2
2022
3622
0.030
Why?
Meta-Analysis as Topic
1
2017
87
0.030
Why?
Triple Negative Breast Neoplasms
1
2020
218
0.030
Why?
Aryl Hydrocarbon Hydroxylases
1
2017
45
0.030
Why?
Chromosomes, Human, Pair 11
1
2016
106
0.030
Why?
Allelic Imbalance
1
2016
22
0.030
Why?
Carcinogenesis
1
2018
243
0.030
Why?
Loss of Heterozygosity
1
2016
85
0.030
Why?
RNA Splice Sites
1
2016
60
0.030
Why?
Incidence
1
2020
1798
0.030
Why?
Thyroid Neoplasms
1
2020
470
0.030
Why?
Public Health
1
2017
163
0.030
Why?
Physicians, Primary Care
1
2017
108
0.030
Why?
Gastric Mucosa
1
2016
73
0.030
Why?
Neoplasm Proteins
1
2019
553
0.030
Why?
Mice, Knockout
1
2020
2217
0.030
Why?
Neoplasm Grading
1
2016
425
0.030
Why?
Sequence Alignment
1
2015
353
0.030
Why?
Nucleotides
1
2015
93
0.030
Why?
Genetic Linkage
1
2016
613
0.030
Why?
Smoking
1
2019
676
0.030
Why?
Cluster Analysis
1
2015
401
0.030
Why?
Lysine
1
2015
170
0.030
Why?
Self Report
1
2016
357
0.030
Why?
Reproducibility of Results
1
2020
2799
0.030
Why?
RNA Splicing
1
2016
163
0.030
Why?
Alternative Splicing
1
2016
226
0.030
Why?
Treatment Outcome
2
2019
9806
0.030
Why?
Haplotypes
1
2016
657
0.030
Why?
Mental Disorders
1
2019
490
0.030
Why?
Age of Onset
1
2015
369
0.030
Why?
Neoplasm Invasiveness
1
2015
583
0.030
Why?
Enhancer Elements, Genetic
1
2016
300
0.030
Why?
Animals
3
2020
29045
0.020
Why?
Gene-Environment Interaction
1
2014
125
0.020
Why?
Base Sequence
1
2016
2224
0.020
Why?
Skin
1
2015
592
0.020
Why?
Amino Acid Sequence
1
2015
2011
0.020
Why?
Attitude of Health Personnel
1
2017
688
0.020
Why?
Logistic Models
1
2015
1276
0.020
Why?
Molecular Sequence Data
1
2015
2897
0.020
Why?
Data Collection
1
2012
376
0.020
Why?
Phosphorylation
1
2013
1148
0.020
Why?
Fibroblasts
1
2013
767
0.020
Why?
Survival Rate
1
2014
2057
0.020
Why?
Patient Selection
1
2014
725
0.020
Why?
Kidney Failure, Chronic
1
2014
451
0.020
Why?
Disease Progression
1
2014
1621
0.020
Why?
Predictive Value of Tests
1
2014
1792
0.020
Why?
Carcinoma, Renal Cell
1
2013
384
0.020
Why?
Kidney
1
2014
1126
0.020
Why?
Registries
1
2014
1133
0.020
Why?
Kidney Neoplasms
1
2013
556
0.020
Why?
Quality of Life
1
2016
1904
0.020
Why?
Follow-Up Studies
1
2014
4049
0.020
Why?
Neoplasm Recurrence, Local
1
2014
1538
0.020
Why?
Cell Line, Tumor
1
2013
2913
0.020
Why?
Time Factors
1
2014
5586
0.010
Why?
Platelet Glycoprotein GPIb-IX Complex
1
2000
7
0.010
Why?
Consensus Sequence
1
2000
63
0.010
Why?
Africa
1
2000
114
0.010
Why?
Chromosomes, Human, Pair 17
1
2000
110
0.010
Why?
Family Health
1
2000
157
0.010
Why?
Microsatellite Repeats
1
2000
150
0.010
Why?
Polymorphism, Genetic
1
2000
832
0.010
Why?
Hulick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (314)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_